Should We Routinely Screen for Warfarin Gene Polymorphism in Patients with Coumadin Overdose?
Genetic polymorphisms can affect an individual's response to the pharmacological agents. Warfarin has a narrow therapeutic range and dose arrangement may vary from individual to individual. An insufficient dose may fail to prevent thromboembolism and overdose may increase the risk of bleeding....
Main Authors: | Enes Elvin Gül, Halil İbrahim Erdoğan, Mehmet Yazıcı |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2016-12-01
|
Series: | Eurasian Journal of Emergency Medicine |
Subjects: | |
Online Access: |
http://akademikaciltip.com/archives/archive-detail/article-preview/should-we-routinely-screen-for-warfarin-gene-polym/21808
|
Similar Items
-
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01) -
Evaluation of the VKORC 1 and CYP2C9 Gene Polymorphisms and Their Effects on the Emergency Complications in the Patients Using Warfarin
by: Oğuz Yardım, et al.
Published: (2017-06-01) -
New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model
by: Karine Rodríguez-Fernández, et al.
Published: (2024-01-01) -
One Rare Warfarin Resistance Case and Possible Mechanism Exploration
by: Zhao L, et al.
Published: (2023-06-01) -
Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
by: Behzad Poopak, et al.
Published: (2016-02-01)